Account
Insider Insights
23.01.2023
Germany – European joint assessment at deadlock ...

Germany's BPI and vfa advise that the implementation of the European Health Technology Assessment (E...

Read more
Articles
11.01.2023
What are the 5 Pricing & Market Access trends ...

Our experts provide an overview of the five key trends that could shape the pricing and market acces...

Read more
Newsletter
04.01.2023
PMA Insights: Week 1

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Articles
08.12.2022
EU HTA – looking back on 2022

Our market access experts cover the changes to the joint EU HTA process that occurred in 2022 and wh...

Read more
Webinar
08.12.2022
Are you ready for the new EU HTA in 2025?

Webinar: Our experts discuss the latest news and updates on the EU HTA process, including the Joint ...

Read more
Publications
07.11.2022
ISPOR 2022 Plenary Session 1 - HTA and Regulation

Our experts provide a detailed summary of Plenary Session 1 at ISPOR 2022 on the Convergence of HTA ...

Read more
Articles
03.08.2022
EU Joint HTA: How will EUNetHTA balance contrastin...

Our Market Access analysts summarise the EUnetHTA draft scoping process and provide considerations a...

Read more
Articles
28.06.2022
EU Joint HTA: How will EUNetHTA balance contrastin...

The EUNetHTA recently published its draft scoping guidance which outlines how the contrasting decisi...

Read more
Articles
05.12.2016
Theory of multiple criteria decision analysis

Multi-criteria decision analysis (MCDA) is a potentially useful tool that can be used to support dec...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch